TENAX THERAPEUTICS INC COM NEW is a security (CUSIP 88032L605) tracked across SEC portfolio filings. 89 institutional managers reported $290.1M on Form 13F as of 2026-06-30; 5 registered fund positions totaling $43.5M via N-PORT as of 2026-04-30.
Showing 15 of 89 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $29.1M | 1,815,474 |
| VR Adviser, LLC | NEW YORK, NY | $26.8M | 1,675,262 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $23.2M | 1,447,782 |
| Ikarian Capital, LLC | DALLAS, TX | $18.1M | 1,017,600 |
| Stonepine Capital Management, LLC | Bend, OR | $15.6M | 975,200 |
| Logos Global Management LP | San Francisco, CA | $10.0M | 625,000 |
| MORGAN STANLEY | NEW YORK, NY | $9.5M | 596,564 |
| Velan Capital Investment Management LP | Alpharetta, GA | $9.3M | 583,333 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Boston, MA | $8.6M | 540,126 |
| Point72 Asset Management, L.P. | Stamford, CT | $8.5M | 533,965 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $8.5M | 533,889 |
| ARMISTICE CAPITAL, LLC | NEW YORK, NY | $7.7M | 478,827 |
| Siren, L.L.C. | New York, NY | $6.8M | 427,141 |
| BOOTHBAY FUND MANAGEMENT, LLC | NEW YORK, NY | $6.4M | 366,791 |
| UBS Group AG | Zurich, V8 | $6.1M | 381,419 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $39.7M | 36.42% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $2.4M | 36.55% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $1.0M | 0.13% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $307K | 0.41% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $81K | 0.01% |